Dependence of Cathepsin L –induced Coronary Endothelial Dysfunction upon Activation of NAD(P)H Oxidase
暂无分享,去创建一个
[1] Si Jin,et al. Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[2] Si Jin,et al. Local production of O2- by NAD(P)H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: cADPR-mediated Ca2+ regulation. , 2008, Cellular signalling.
[3] Yang Zhang,et al. Critical Role of Lipid Raft Redox Signaling Platforms in Endostatin-Induced Coronary Endothelial Dysfunction , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[4] Christoph Peters,et al. Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice , 2007, Circulation.
[5] Pin-Lan Li,et al. Production of NAADP and its role in Ca2+ mobilization associated with lysosomes in coronary arterial myocytes. , 2006, American journal of physiology. Heart and circulatory physiology.
[6] F. Sellke,et al. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. , 2006, The Annals of thoracic surgery.
[7] E. Gulbins,et al. Lipid Raft Clustering and Redox Signaling Platform Formation in Coronary Arterial Endothelial Cells , 2006, Hypertension.
[8] K. Moulton,et al. Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosiss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional figure Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500241-JLR200 , 2005, Journal of Lipid Research.
[9] W. Campbell,et al. Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2*- production in the intact coronary endothelium. , 2005, American journal of physiology. Heart and circulatory physiology.
[10] D. Zurakowski,et al. Loss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis , 2004, Circulation.
[11] Pin-Lan Li,et al. Enhanced production and action of cyclic ADP-ribose during oxidative stress in small bovine coronary arterial smooth muscle. , 2004, Microvascular research.
[12] Tiansen Li,et al. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function , 2004, The EMBO journal.
[13] M. Bogyo,et al. Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones , 2004, Biological chemistry.
[14] F. Yi,et al. Simultaneous in situ monitoring of intracellular Ca2+ and NO in endothelium of coronary arteries. , 2002, American journal of physiology. Heart and circulatory physiology.
[15] E. Chavakis,et al. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti‐angiogenic effects of endostatin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] J. Falck,et al. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. , 2002, American journal of physiology. Heart and circulatory physiology.
[17] J. Kos,et al. Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[18] D. Harrison,et al. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.
[19] H. Ploegh,et al. Secreted cathepsin L generates endostatin from collagen XVIII , 2000, The EMBO journal.
[20] W. Campbell,et al. 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. , 1999, Circulation research.
[21] V. Sukhatme,et al. Cloning, Expression, andin VitroActivity of Human Endostatin , 1999 .
[22] V. Sukhatme,et al. Endostatin Induces Endothelial Cell Apoptosis* , 1999, The Journal of Biological Chemistry.
[23] Sheila J. Jones,et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Timpl,et al. Structure, function and tissue forms of the C‐terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin , 1998, The EMBO journal.
[25] S. Kawahara,et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. , 1998, Analytical chemistry.
[26] A. Rudensky,et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.
[27] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[28] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[29] M. Seldin,et al. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. , 1994, Genomics.
[30] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[31] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[32] W. Campbell,et al. Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries. , 2000, Hypertension.